Omri Amirav-Drory

General Partner
Two-time scientist-founder, including Genome Compiler and founding CEO at Tech.Bio. Currently heading NFX Bio.

Investor scope

Investment criteria breakdown.
Investment stages
Pre-Seed
Seed
Target regions
USA
Israel
Latin America
Investment ranges
$100K - $500K
$500K - $1M
$1M - $3M
$3M - $10M
Focus areas
Biotech
Gaming & VR
Web3
Deeptech
Fintech
Marketplaces

Related unicorns

A glimpse at some of the $1B+ valuation companies backed by this fund.

Investors targeting related sectors

Nataniel Elkaim
Partner
View profile
Michael Amar
General Partner
View profile
Sriram Krishnan
General Partner
View profile
Shriya Nevatia
Principal
View profile
Nan Li
Partner
View profile
Mat Vogels
Partner
View profile
Maya Bakhai
General Partner
View profile
Charlton Hook
Investment Director
View profile
Rafael Melo
Co-Founder and CEO
View profile
Annie Kadavy
Managing Director
View profile
Malte Barth
Founding General Partner
View profile
Daniel Lloreda
Co-Founder and Managing Partner
View profile
Ariana Thacker
Founding Partner
View profile
Jyoti Bansal
Co-Founder and Entrepreneur Partner
View profile
Benjamin Quiroga
General Partner
View profile

Related Sector Funds

Funds investing in similar sectors.
V3ntures
Paris
Pre-Seed
Seed
Series A
+ND Capital Fund)
Cayman Islands
Seed
Series A
Series B+
11.2 Capital
San Francisco, California
Pre-Seed
Seed
Series A
Series B+
01 Advisors Fund
San Francisco, California
Series A
Series B+
1955 Capital
San Francisco, California
Pre-Seed
Seed
2048 Ventures
United States
Seed
Series A
1Up Ventures
Europe
Seed
Series A
1kx
San Francisco, California
Pre-Seed
Seed
25M Health
New York, New York
Pre-Seed
Seed
3CC | Third Culture Capital
Boston, Massachusetts
Pre-Seed
Seed
Series A
5AM Ventures
San Francisco, California
Seed
Series A
7percent Ventures
London, United Kingdom
Pre-Seed
Seed
Series A
6th Man Ventures (6MV)
New York, New York
Pre-Seed
Seed
Series A
8VC
Austin, Texas
Pre-Seed
Seed
Series A
Series B+

Browse more categories